[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwAMnYGJN6aczmkLKnn5ZUUh3MPfHl4EVOk0_dXi5dw0":8,"$fZ0nCHghXpusht9hVkPiCQkdnXXPmzWLK5PxQEUXKQ28":54,"$fCCa8c-dy3iYJrTFwoJU16ieEKTR5oBtf6yhEVjmHqSM":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":20,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":21,"isComment":41},68420,870792,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//sLW9CbudsONMAqEvkoMkEqohZ3fXL0QF.png","白瑞","浙江大学医学院附属第二医院","肿瘤科","副主任医师",2,0,"靶向药与化疗药的联合用药：直肠癌肝转移治疗中的科学用药指南","","https://ystcdn.venuertc.com/venue/AI/5367f5ac-8c9a-46a3-bfb8-0220cebe862f.jpg","\u003Cdiv class=\"pharma-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"pharma-material-title\">靶向药与化疗药的联合用药：直肠癌肝转移治疗中的科学用药指南\u003C/h1>\n  \n  \u003Cdiv class=\"pharma-material-section pharma-background-1\">\n    \u003Ch2 class=\"pharma-material-subtitle\">进入主题：精准用药保障治疗效果 🚦\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      靶向药物和化疗药物在肿瘤治疗中经常联合应用，优化了疗效。不过，这些药品的用法用量、相互作用以及常见不良反应都有充分细致的规定，对使用者的要求也比较高。今天，我们结合真实用药案例，梳理7个常见药品（以西妥昔单抗、伊立替康脂质体、氟尿嘧啶为代表）的正确使用细节，包括服用、剂型处理、相互作用、特殊人群处理、不良反应与储存等，助你打下用药安全的坚实基础。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-2\">\n    \u003Ch2 class=\"pharma-material-subtitle\">1. 药品成分、剂型、规格：认清药物基本信息 🔎\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      药品种类多样，本案例涉及三大类：\u003Cspan class=\"pharma-key\">西妥昔单抗（靶向药）、伊立替康脂质体与氟尿嘧啶（化疗药）\u003C/span>。\u003Cbr>\n      \u003Cstrong>西妥昔单抗\u003C/strong> ：单克隆抗体药物，常见于注射剂型（多为250mg/5ml规格）。\u003Cbr>\n      \u003Cstrong>伊立替康脂质体\u003C/strong> ：脂质体包裹的化疗药，静脉输注，常见规格为100mg/10ml等。\u003Cbr>\n      \u003Cstrong>氟尿嘧啶\u003C/strong> ：注射液（500mg/10ml为常用规格），也有片剂\u003Cbr>\n      \u003Cspan class=\"pharma-highlight\">正确做法：\u003C/span>了解药品全名、剂型、规格，用药前确认药品标签，避免拿错或混用。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-3\">\n    \u003Ch2 class=\"pharma-material-subtitle\">2. 作用机制简述：为何联合用药？\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      不同药物各有分工。\u003Cbr>\n      西妥昔单抗通过和肿瘤细胞表面的EGFR结合，阻断信号传递，抑制肿瘤细胞生长。\u003Cbr>\n      伊立替康脂质体则干扰肿瘤DNA复制和分裂，使癌细胞凋亡。\u003Cbr>\n      氟尿嘧啶能够抑制DNA合成，防止癌细胞增殖。\u003Cbr>\n      \u003Cspan class=\"pharma-highlight\">联合应用，可从多个通路抑制肿瘤进展。\u003C/span>\u003Cbr>\u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-4\">\n    \u003Ch2 class=\"pharma-material-subtitle\">3. 用法用量要讲究：每种药物分别处理 💉\u003C/h2>\n    \u003Cul class=\"pharma-material-ul\">\n      \u003Cli>\n        \u003Cstrong>西妥昔单抗\u003C/strong>：仅限静脉滴注，由医务人员严格按照体表面积和方案计算剂量给药。\u003Cbr>\n        \u003Cspan class=\"pharma-highlight\">不得自行更改剂量或注射速度。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊立替康脂质体\u003C/strong>：同为静脉输注，用专用输液泵缓慢滴注（一般大于60分钟）。\u003Cbr>\n        \u003Cspan class=\"pharma-highlight\">禁止口服或自行注射。\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>氟尿嘧啶\u003C/strong>：注射剂不可口服，需静脉推注或持续滴注。\u003Cbr>\n        \u003Cspan class=\"pharma-highlight\">用量须根据患者方案调整，勿随意中断或加量。\u003C/span>\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>三药均应由医院专业人员根据体重、治疗周期给药。患者需按约定时间到院，切勿自行处理药品。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-5\">\n    \u003Ch2 class=\"pharma-material-subtitle\">4. 剂型与服用技巧：静脉用药要注意什么？\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      这里涉及的药全部为静脉制剂，\u003Cspan class=\"pharma-key\">不可改为口服、嚼服或粉碎\u003C/span>。\u003Cbr>\n      \u003Cstrong>西妥昔单抗\u003C/strong>为蛋白类制剂，需使用专用输液管，避免剧烈摇晃，防止蛋白变性。\u003Cbr>\n      \u003Cstrong>伊立替康脂质体\u003C/strong>应在避光条件下输注；药液如出现絮状沉淀需丢弃，不可注射。\u003Cbr>\n      \u003Cstrong>氟尿嘧啶\u003C/strong>必须经稀释后输注，避免稀释不足导致药物刺激血管甚至外渗。\u003Cbr>\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>严格按照医院输液流程执行，发现药液异常及时告知医护，不得自行处理。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-6\">\n    \u003Ch2 class=\"pharma-material-subtitle\">5. 药物相互作用：联合用药有讲究 ⚠️\u003C/h2>\n    \u003Cul class=\"pharma-material-ul\">\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">伊立替康脂质体\u003C/span>与CYP3A4抑制剂（如某些抗生素、抗真菌药）合用时，体内浓度可能升高，毒性增加。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">氟尿嘧啶\u003C/span>与甲氨蝶呤等抗代谢药合用时，会加重毒副反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">西妥昔单抗\u003C/span>有可能加重与其他免疫相关药品的相互副作用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">严重肝肾损伤\u003C/span>可能改变药物代谢，应告知医生所有正在服用的药品（包括保健品、抗高血压药）。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>就医前如实告知全部用药历史。单独服用维生素、补剂等也不可忽视药物互动风险。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-7\">\n    \u003Ch2 class=\"pharma-material-subtitle\">6. 用药注意事项与禁忌：哪些情况说“NO”？🚫\u003C/h2>\n    \u003Cul class=\"pharma-material-ul\">\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">西妥昔单抗\u003C/span>：已知对鼠源蛋白或对本品过敏者绝对禁用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">伊立替康脂质体\u003C/span>：重度骨髓抑制、活动性感染、肝功能衰竭、孕妇禁止使用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"pharma-highlight\">氟尿嘧啶\u003C/span>：严重骨髓抑制、明显肝肾损伤、孕妇、哺乳期妇女禁用。\n      \u003C/li>\n      \u003Cli>\n        老年及特殊体质者，需根据药代动力学监测结果个体化调整剂量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">特别提醒：\u003C/span>禁忌并非个别规则，而是严格针对药品成分与不良反应设定。不要抱有“试也无妨”的心理。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-8\">\n    \u003Ch2 class=\"pharma-material-subtitle\">7. 常见不良反应及处理方法：警惕身体信号\u003C/h2>\n    \u003Cul class=\"pharma-material-ul\">\n      \u003Cli>\u003Cstrong>西妥昔单抗：\u003C/strong> 短期内最常见为皮肤反应（如痤疮样皮疹）；部分患者可有输液反应，包括发热、寒战。少见但严重者有过敏反应或呼吸困难等。\u003C/li>\n      \u003Cli>\u003Cstrong>伊立替康脂质体：\u003C/strong> 呕吐、腹泻多见，需要密切监测；极少数人出现重度中性粒细胞减少。\u003C/li>\n      \u003Cli>\u003Cstrong>氟尿嘧啶：\u003C/strong> 可出现骨髓抑制、口腔炎、皮炎及消化道反应。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>用药后出现不适立刻通知医护人员，尤其是过敏、呼吸困难等严重信号。部分反应可通过提前使用止吐、护胃等药物缓解，切勿自行停药。\n      \u003Cbr>\n      \u003Cspan class=\"pharma-number\">临床研究显示：\u003C/span>西妥昔单抗相关皮肤毒性发生率高达70%。\u003Cspan class=\"pharma-cite\">（Van Cutsem E, et al., 2009）\u003C/span>\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-9\">\n    \u003Ch2 class=\"pharma-material-subtitle\">8. 特殊人群用药：老年人和慢性病患者须调整 🎯\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cstrong>老年人：\u003C/strong>肝肾功能减退时，需监测血象及肝肾功能，可能需适当减少剂量。\u003Cbr>\n      \u003Cstrong>合并其他慢性疾病者：\u003C/strong>如有高血压、冠心病等，应提前评估用药相互作用。部分高龄患者长期服用多种药物，需防止药物积聚或相互增强毒副作用。\u003Cbr>\n      \u003Cstrong>孕妇、哺乳期及儿童：\u003C/strong>目前安全性尚不明确，均应避免使用。\n    \u003C/p>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>用药前告知医生详细病史及用药清单，定期检测肝肾功能和血象，保证安全。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-10\">\n    \u003Ch2 class=\"pharma-material-subtitle\">9. 储存方法及有效期：科学保存每一剂药物 🗃️\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cstrong>西妥昔单抗：\u003C/strong>需在2-8°C冷藏，勿冷冻，避光保存。\u003Cbr>\n      \u003Cstrong>伊立替康脂质体：\u003C/strong>冷藏保存（2-8°C），药液混悬后应尽快使用，最长不超24小时。\u003Cbr>\n      \u003Cstrong>氟尿嘧啶：\u003C/strong>室温（15-25°C）避光保存，开封后剩余药液应丢弃，不得留用。过期药不可用，需依法销毁。\u003Cbr>\n      \u003Cspan class=\"pharma-remind\">正确做法：\u003C/span>使用前仔细核实药品标签、批号与有效期。家中如非必要，建议不自行保存静脉药品。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-11\">\n    \u003Ch2 class=\"pharma-material-subtitle\">10. 案例与细节总结\u003C/h2>\n    \u003Cul class=\"pharma-material-ul\">\n      \u003Cli>有位61岁男性按医嘱联合应用西妥昔单抗、伊立替康脂质体及氟尿嘧啶，未出现显著恶心、呕吐或消化道出血，治疗期间体重保持稳定。这说明严格执行医嘱、有针对性预防不良反应是安全用药的关键。\u003C/li>\n      \u003Cli>临床中，部分患者因未通报正在服用保健品与抗生素，联合服药后致毒副作用增加，提示所有药品都需主动报备。\u003C/li>\n    \u003C/ul>\n    \u003Cp class=\"pharma-material-p\">\n      \u003Cspan class=\"pharma-remind\">一句总结：\u003C/span>安全用药贵在细致和如实沟通，事无巨细。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-12\">\n    \u003Ch2 class=\"pharma-material-subtitle\">结语：科学用药，护航每一次治疗\u003C/h2>\n    \u003Cp class=\"pharma-material-p\">\n      靶向药与化疗药的合理联合，为患者带来新希望。但科学的用药要求更为严苛。牢记用药规则，及时告知医生突发状况，是提高疗效、减少风险的最大保障。安全用药，从每一次小细节做起。遇到疑问时，务必第一时间咨询医疗专业人员。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"pharma-material-section pharma-background-refer\">\n    \u003Ch2 class=\"pharma-material-subtitle\">参考文献\u003C/h2>\n      \u003Col class=\"pharma-material-ol\">\n        \u003Cli>Van Cutsem E, Köhne C-H, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. \u003Ci>New England Journal of Medicine\u003C/i>. 2009;360(14):1408-1417. https://doi.org/10.1056/NEJMoa0805019\u003C/li>\n        \u003Cli>Wakabayashi M, et al. Liposomal irinotecan in metastatic colorectal cancer: A review of current evidence. \u003Ci>Cancer Manag Res\u003C/i>. 2020;12:13339-13352. https://doi.org/10.2147/CMAR.S282922\u003C/li>\n        \u003Cli>Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. \u003Ci>Nat Rev Cancer\u003C/i>. 2003;3(5):330-338. https://doi.org/10.1038/nrc1074\u003C/li>\n      \u003C/ol>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.pharma-material-container { \n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Hiragino Sans GB', 'Microsoft YaHei', sans-serif; \n  margin: 40px auto 60px auto; \n  max-width: 820px; \n  background: #fafcfd; \n  border-radius: 14px; \n  box-shadow: 0 6px 14px rgba(50,70,120,0.11);\n  padding:36px 32px 36px 32px;\n}\n\n.pharma-material-title {\n  font-size: 2.2rem;\n  font-weight: bold;\n  letter-spacing: .08em;\n  text-align: center;\n  margin-bottom: 42px;\n  color: #2e384d;\n}\n\n.pharma-material-section {\n  margin-bottom: 28px;\n  border-radius:12px;\n  padding:24px 18px 20px 18px;\n  box-sizing:border-box;\n}\n\n.pharma-background-1 { background: linear-gradient(90deg,#f7efe2 0%,#f3fbf8 100%); }\n.pharma-background-2 { background: linear-gradient(92deg,#f3f4f8 0%,#dfe8ee 100%); }\n.pharma-background-3 { background: linear-gradient(87deg,#eef6f7 50%,#f7efda 100%); }\n.pharma-background-4 { background: linear-gradient(90deg,#f7fbf7 0%,#f2f2fa 100%); }\n.pharma-background-5 { background: linear-gradient(100deg,#f3f0fc 0%,#f5f6fd 100%); }\n.pharma-background-6 { background: linear-gradient(98deg,#f3fcfb 0%,#ffe9e1 100%); }\n.pharma-background-7 { background: linear-gradient(85deg,#f9eefd 0%,#f3f7fc 100%); }\n.pharma-background-8 { background: linear-gradient(99deg,#f1faf6 0%,#ffeada 100%); }\n.pharma-background-9 { background: linear-gradient(90deg,#f7fcfe 0%,#e9edfa 100%); }\n.pharma-background-10 { background: linear-gradient(92deg,#f1f1eb 0%,#f3fb 100%); }\n.pharma-background-11 { background: linear-gradient(90deg,#e0f7f3 0%,#f5f0f5 100%); }\n.pharma-background-12 { background: linear-gradient(99deg,#fefdff 0%, #eafbf5 100%);}\n.pharma-background-refer { background: linear-gradient(99deg,#f3f8ff 0%,#f7f6fb 100%);}\n\n.pharma-material-subtitle {\n  font-size: 1.24rem;\n  font-weight: bold;\n  color: #385375;\n  margin:0 0 12px 0;\n  padding:0;\n  letter-spacing:.03em;\n  line-height: 1.3;\n  background: none;\n}\n\n.pharma-material-p {\n  line-height: 1.76;\n  color: #3f475c;\n  margin-bottom:1em;\n  font-size:1.06rem;\n}\n\n.pharma-key {\n  color: #1b9aaa; font-weight:500;\n}\n.pharma-number {\n  color: #a86c31;font-weight: bold; font-size:.98rem;\n}\n.pharma-cite {\n  color: #91a4da;font-size:.95em; font-style:italic;\n}\n.pharma-remind, .pharma-highlight {\n  color: #ec4d0b;\n  font-weight: bold;\n}\n\n.pharma-material-ul {\n  margin-top: 0;\n  margin-bottom: .9em;\n  padding-left: 26px;\n}\n.pharma-material-ul li {\n  font-size: 1.04rem;\n  color: #465672;\n  line-height: 1.6;\n  margin-bottom:.34em;\n  list-style: disc;\n}\n\n.pharma-material-ol {\n  margin: 0 0 0 20px;\n  padding: 0;\n  color: #4b547a;\n  font-size:1.03rem;\n}\n\n.pharma-material-ol li {\n  margin-bottom:.45em;\n}\n\n@media (max-width:700px){\n  .pharma-material-container {padding:18px 0 28px 0;}\n  .pharma-material-section{ padding:18px 8px 18px 8px;}\n  .pharma-material-title{font-size:1.26rem;}\n  .pharma-material-subtitle{font-size:1.03rem;}\n}\n\u003C/style>","\u003Cdiv class=\"pharma-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"pharma-material-title\">靶向药与",538,"2025-10-24 00:15:42","靶向药,化疗药,直肠癌,联合用药,用药指南,不良反应,肝转移,药物相互作用","深入了解靶向药与化疗药的结合使用，提升直肠癌肝转移治疗效果，掌握用药原则和注意事项，确保安全和疗效。","2025-11-09 22:30:00",[33],{"menuId":34,"menuName":35,"parentId":21,"orderNum":20,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":21,"createDept":6,"remark":23,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":21,"forceLogin":21,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]